» Articles » PMID: 36453399

Decoding Degeneration: the Implementation of Machine Learning for Clinical Detection of Neurodegenerative Disorders

Overview
Date 2022 Dec 1
PMID 36453399
Authors
Affiliations
Soon will be listed here.
Abstract

Machine learning represents a growing subfield of artificial intelligence with much promise in the diagnosis, treatment, and tracking of complex conditions, including neurodegenerative disorders such as Alzheimer's and Parkinson's diseases. While no definitive methods of diagnosis or treatment exist for either disease, researchers have implemented machine learning algorithms with neuroimaging and motion-tracking technology to analyze pathologically relevant symptoms and biomarkers. Deep learning algorithms such as neural networks and complex combined architectures have proven capable of tracking disease-linked changes in brain structure and physiology as well as patient motor and cognitive symptoms and responses to treatment. However, such techniques require further development aimed at improving transparency, adaptability, and reproducibility. In this review, we provide an overview of existing neuroimaging technologies and supervised and unsupervised machine learning techniques with their current applications in the context of Alzheimer's and Parkinson's diseases.

Citing Articles

Harnessing Artificial Intelligence for the Detection and Management of Colorectal Cancer Treatment.

Jacob M, Reddy R, Garcia R, Reddy A, Khemka S, Roghani A Cancer Prev Res (Phila). 2024; 17(11):499-515.

PMID: 39077801 PMC: 11534518. DOI: 10.1158/1940-6207.CAPR-24-0178.


Differential distribution of PINK1 and Parkin in the primate brain implies distinct roles.

Liu Y, Huang W, Wen J, Xiong X, Xu T, Wang Q Neural Regen Res. 2024; 20(4):1124-1134.

PMID: 38989951 PMC: 11438320. DOI: 10.4103/NRR.NRR-D-23-01140.


Detecting Parkinson's disease from shoe-mounted accelerometer sensors using convolutional neural networks optimized with modified metaheuristics.

Jovanovic L, Damasevicius R, Matic R, Kabiljo M, Simic V, Kunjadic G PeerJ Comput Sci. 2024; 10:e2031.

PMID: 38855236 PMC: 11157549. DOI: 10.7717/peerj-cs.2031.


Artificial intelligence-assisted repair of peripheral nerve injury: a new research hotspot and associated challenges.

Guo Y, Sun L, Zhong W, Zhang N, Zhao Z, Tian W Neural Regen Res. 2023; 19(3):663-670.

PMID: 37721299 PMC: 10581578. DOI: 10.4103/1673-5374.380909.


Editorial: Insights into structural and functional organization of the brain: evidence from neuroimaging and non-invasive brain stimulation techniques.

Tanaka M, Diano M, Battaglia S Front Psychiatry. 2023; 14:1225755.

PMID: 37377471 PMC: 10291688. DOI: 10.3389/fpsyt.2023.1225755.


References
1.
Ni R, Nitsch R . Recent Developments in Positron Emission Tomography Tracers for Proteinopathies Imaging in Dementia. Front Aging Neurosci. 2022; 13:751897. PMC: 8761855. DOI: 10.3389/fnagi.2021.751897. View

2.
Bao W, Xie F, Zuo C, Guan Y, Huang Y . PET Neuroimaging of Alzheimer's Disease: Radiotracers and Their Utility in Clinical Research. Front Aging Neurosci. 2021; 13:624330. PMC: 8134674. DOI: 10.3389/fnagi.2021.624330. View

3.
Liu C, Wei H, Gong N, Cronin M, Dibb R, Decker K . Quantitative Susceptibility Mapping: Contrast Mechanisms and Clinical Applications. Tomography. 2016; 1(1):3-17. PMC: 4734903. DOI: 10.18383/j.tom.2015.00136. View

4.
Colombi I, Mahajani S, Frega M, Gasparini L, Chiappalone M . Effects of antiepileptic drugs on hippocampal neurons coupled to micro-electrode arrays. Front Neuroeng. 2013; 6:10. PMC: 3832899. DOI: 10.3389/fneng.2013.00010. View

5.
Blennow K, de Leon M, Zetterberg H . Alzheimer's disease. Lancet. 2006; 368(9533):387-403. DOI: 10.1016/S0140-6736(06)69113-7. View